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Abstract: Cardiovascular disease (CVD) and associated behavioural and metabolic risk factors
constitute a major public health concern at a global level. Many reports worldwide have documented
different risk profiles for populations with demographic variations. The objective of this study was to
examine geographic variations in the top leading cardio metabolic and behavioural risk factors in
Luxembourg, in order to provide an overall picture of CVD burden across the country. The analysis
conducted was based on data from the nationwide ORISCAV-LUX survey, including 1432 subjects,
aged 18–69 years. A self-reported questionnaire, physical examination and blood sampling were
performed. Age and sex-adjusted risk profile maps were generated using multivariate Bayesian
geo-additive regression models, based on Markov Chain Monte Carlo techniques and were used to
evaluate the significance of the spatial effects on the distribution of a range of cardio metabolic risk
factors, namely smoking, high body mass index (BMI), high blood pressure, high fasting plasma
glucose, alcohol use, high total cholesterol, low glomerular filtration rate, and physical inactivity.
Higher prevalence of smoking was observed in the northern regions, higher overweight/obesity and
abdominal obesity clustered in the central belt, whereas hypertension was spotted particularly in
the southern part of the country. Maps revealed that subjects residing in Luxembourg canton were
significantly less likely to be hypertensive or overweight/obese, whereas they were less likely to
practice physical activity of ≥8000 Metabolic Equivalent of Task (MET)-min/week. These patterns
were also observed at the municipality level in Luxembourg. Statistically, there were non-significant
spatial patterns regarding smoking, diabetes, total serum cholesterol and low glomerular filtration
rate risk distribution. This comprehensive risk profile mapping showed remarkable geographic
variations in cardio metabolic and behavioural risk factors. Considering the prominent burden of
CVD this research provides opportunities for tailored interventions and may help to better fight
against this escalating public health problem.
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1. Introduction
Cardiovascular disease (CVD) and associated behavioural and metabolic risk factors constitute
a major public health concern not only in Europe and Luxembourg but at a global level. In 2010,
ischemic heart disease and stroke collectively killed 12.9 million people or one in four deaths
worldwide, compared with one in five in 1990; 1.3 million deaths were due to diabetes, which doubled
since 1990 [1]. These diseases, which primarily cause avoidable premature death, were among the top
15 causes of Disability-Adjusted Life-Years (DALYs) globally [2].
Additionally, the Global Burden of Disease, Injuries, and Risk Factor study in 2013 (GBD 2013)
identified that smoking, high body mass index (BMI), high blood pressure (BP), high fasting plasma
glucose (FPG), alcohol use, high total cholesterol (TC), low glomerular filtration rate (GFR), physical
inactivity, drug use and high intake of processed meat were the top ten leading causes of DALYs for
both sexes in Luxembourg [3]. This national pattern converged with most high-income countries,
calling attention to the important impact of these diseases and associated pathologies on population
health, individual and societal well-being, as well as to their burden on national health care system.
Previous research has demonstrated substantial variations in CVD burden. Many country-specific
reports have documented different risk profiles for populations with demographic variations [4–8].
In Luxembourg, the most recent national estimates for the prevalence of hypertension, diabetes,
dyslipidaemia, smoking and obesity for adults were at 34.5%, 4.4%, 69.9%, 22.3% and 20.9%,
respectively [8]. All prevalence rates increased with age (except smoking), with marked gender
differences (except diabetes). Furthermore, there was a significant difference in the prevalence of
hypertension and lipid disorders by subject’s country of birth [8].
Recently, evidence regarding geographic variations in cardiovascular risk profiles was reported
among provinces in Canada [9], among women in cities of the United States [10], between southern and
northern populations of China [11], in Malaysia [12] and in African populations [13,14]. Studies have
found that risk factors tend to cluster within socially disadvantaged regions. After controlling for
socioeconomic status (SES), regional effects do exist, although tend to be small compared to individual
effects related to lifestyle [9,15]. Research also indicates that no single parameter can explain differences
driven by the geographic location of a community. Jarvie et al. underlined that multiple factors make
up a community, such as racial and ethnic majorities, education, and income, in addition to local
conditions that affect lifestyle, such as climate, grocery stores, transportation, safety and availability of
parks and open spaces. Therefore, regional variation is likely to reflect the complex interplay between
a region and the inhabiting population [10].
While the distribution of cardiovascular risk factors [8] and risk profile variations [16] have been
well documented in Luxembourg, information regarding the geographical variation has not yet been
reported. Most public health research has focused on person and time, with little consideration of
the implications of space dimension on disease processes [17–19]. However, evidence regarding the
concentration of a health problem in identifiable places or searching for geographical disease clustering
is essential for an efficient distribution of resources for prevention and treatment [3]. Therefore,
from the perspective of public health practice, understanding the overall picture of CVD burden in
Luxembourg provides opportunities for tailored interventions to improve CVD outcomes. The aim of
this study was to examine geographic variations in the top leading behavioural and cardio metabolic
risk factors [3] among the adult population of residents in Luxembourg by using data from the
Observation of Cardiovascular Risk Factors in Luxembourg (ORISCAV-LUX) survey.
2. Methods
2.1. Studied Population
The ORISCAV-LUX survey, conducted in 2007–2008, is the first population-based study to monitor
cardiovascular risk factors among adults, aged 18 to 69 years, in Luxembourg. This survey involved
a self-reported questionnaire that covered socio-demographic aspects, lifestyle and personal health
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problems. In addition, blood pressure, body weight, height, waist circumference, as well as blood and
urine sampling were performed by well-trained nurses. Further details regarding the measurement of
anthropometric and biochemical parameters are available elsewhere [8,20,21].
The ORISCAV-LUX study employed a stratified random sampling design proportionate to
the population size, according to age, sex and geographical districts (Luxembourg, Diekirch and
Grevenmacher). A detailed description of sampling procedures and sample representativeness was
published elsewhere [22]. Briefly, 1432 participants were recruited, from which two non-residents in
Luxembourg were excluded from the present analyses.
The ORISCAV-LUX study was conducted according to the guidelines laid down in the Declaration
of Helsinki. All procedures involving human subjects were approved by the National Research Ethics
Committee (N200609/03) and the National Commission for Private Data Protection. Written informed
consent was obtained from all subjects (copy available on need). This document has been written in
line with our national legal authorities’ guidelines.
2.2. Outcome Measurement
Based on findings from the GBD study and considering data availability, we focused on
the following top leading behavioural and metabolic risk factors, each identified as binary
outcomes: smoking (current/former smoker vs. never smoked), high BMI (overweight/obesity with
BMI > 25 vs. ≤25), high BP (BP of ≥140 mmHg and/or DBP ≥ 90 mmHg and/or antihypertensive
medications intake vs. no hypertension), high FPG (FPG of ≥126 mg/dL and/or antidiabetic
medications intake vs. no diabetes), alcohol use (daily alcohol drinkers vs. non-drinkers), high
TC (total cholesterol >4.8 mmol/L vs. equal or below this level), low GFR (eGFR <60 mL per min
per 1.73 m2 vs. equal or above this level) and physical inactivity (when physical activity was <8000
Metabolic Equivalent of Task (MET) min per week vs. equal or above this level). Owing to the high
impact of abdominal obesity on cardio metabolic health, we also considered this factor in our analyses,
defined as binary variable (waist circumference (WC) ≥ 102 cm for men and ≥ 88 cm for women vs.
lower than these levels). Table 1.
Table 1. Definitions of top leading behavioural and metabolic risk factors [3].
Top Leading Risk Factors Definition
Smoking Current daily or occasional tobacco consumption
High BMI
(overweight/obesity) Body-mass index > 25 kg/m
2 were considered as overweight/obese [23]
High BP (hypertension) SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg and/or antihypertensivemedications intake [24]
High FPG (diabetes) FPG ≥ 126 mg/dL and/or antidiabetic medications intake [25]
Alcohol use Daily alcohol consumption measured in mL per day
High total cholesterol Total cholesterol >4.8 mmol/L (185.6 mg/dL) [3]
Low GFR (CKD) * eGFR <60 mL per min per 1.73 m2 [26]
Low physical activity Weekly physical activity <8000 Metabolic Equivalent of Task (MET) minper week [3]
High abdominal obesity Waist circumference (WC) ≥ 102 cm for men and ≥88 cm for women [27]
* Estimated glomerular filtration rate (eGFR) = 175 × (Creatinine) − 1.154 × (Age) − 0.203 × (0.742 if female) ×
(1.212 if black) measured in mL/min/1.73 m2, to indicate chronic kidney disease (CKD). BMI, body mass index;
BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; GFR,
glomerular filtration rate.
2.3. Geographical Variables
The independent “explanatory” variable was the participant’s geographic location, measured in
terms of the canton or municipality of residence at the time of the survey. Note that Luxembourg is
administratively divided into 12 cantons and 106 municipalities (Figure 1).
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Figure 1. Map of Luxembourg by cantons (left) and municipalities (right). 1, Beaufort. 2, Bech. 3, 
Beckerich. 4, Berdorf. 5, Bertrange. 6, Bettembourg. 7, Bettendorf. 8, Betzdorf. 9, Bissen. 10, Biwer. 11, 
Boevange-sur-Attert. 12, Boulaide. 13, Bourscheid. 14, Bous. 15, Clervaux. 16, Colmar-Berg. 17, 
Consdorf. 18, Contern. 19, Dalheim. 20, Diekirch. 21, Differdange. 22, Dippach. 23, Dudelange. 24, 
Echternach. 25, Ell. 26, Erpeldange. 27, Esch-sur-Alzette. 28, Esch-sur-Sure. 29, Eschweiler. 30, 
Ettelbruck. 31, Feulen. 32, Fischbach. 33, Flaxweiler. 34, Frisange. 35, Garnich. 36, Goesdorf. 37, 
Grevenmacher. 38, Grosbous. 39, Heffingen. 40, Hesperange. 41, Hobscheid. 42, Junglinster. 43, 
Kaerjen. 44, Kayl. 45, Kehlen. 46, Kiischpelt.47, Koerich. 48, Kopstal. 49, Lac De La Haute Sure. 50, 
Larochette. 51, Lenningen. 52, Leudelange. 53, Lintgen. 54, Lorentzweiler. 55, Luxembourg. 56, 
Mamer. 57, Manternach. 58, Mersch. 59, Mertert. 60, Mertzig. 61, Mompach. 62, Mondercange. 63, 
Mondorf-Les-Bains. 64, Niederanven. 65, Nommern. 66, Parc Hosingen. 67, Petange. 68, Preizerdaul. 
69, Putscheid. 70, Rambrouch. 71, Reckange-sur-Mess. 72, Redange. 73, Reisdorf. 74, Remich. 75, 
Roeser. 76, Rosport. 77, Rumelange. 78, Saeul. 79, Sandweiler. 80, Sanem. 81, Schengen. 82, Schieren. 
83, Schifflange. 84, Schuttrange. 85, Septfontaines. 86, Stadtbredimus. 87, Steinfort. 88, Steinsel. 89, 
Strassen. 90, Tandel. 91, Troisvierges. 92, Tuntange. 93, Useldange. 94, Vallée de L'Ernz. 95, Vianden. 
96, Vichten. 97, Wahl. 98, Waldbillig. 99, Waldbredimus. 100, Walferdange. 101, Weiler-la-Tour. 102, 
Weiswampach. 103, Wiltz. 104, Wincrange. 105, Winseler. 106, Wormeldange. 
2.4. Statistical Analysis 
First, a descriptive analysis of behavioural and metabolic risk factors of the participants was 
performed according to sex and then according to canton and municipality. The statistical 
significance of probable associations between the geographic location (canton and municipality) and 
each behavioural and cardio metabolic risk factor was assessed using chi-square (χ2) and Mann-
Whitney U-tests, as appropriate. 
Then, to account for geographical effects on the prevalence of each risk factor, we employed a 
fully Bayesian approach using Markov Chain Monte Carlo (MCMC) techniques for inference and 
model checking [28]. This was achieved using multivariate Bayesian geo-additive regression models 
adjusted for age and gender; the effect of age on each risk factor was assumed to be linear. The 
standard measure of effect was the posterior odds ratio (POR) and its 95% confidence interval (CI). 
Age- and gender-adjusted odds ratios (ORs) of each risk factor were computed using logistic 
regression models, with women and Luxembourg (at the canton and municipality level) as reference 
categories. Age- and sex-adjusted total residual spatial effects were generated and presented on 
smoothed maps using graduated colouring to represent the risk for each risk factor. To account for 
the stratified random sampling method used to recruit the participants, weighted statistical methods 
were applied to produce nationally representative estimates.  
All descriptive statistical analyses were performed using PASW® for Windows® version 21.0 
software (formerly SPSS Statistics Inc., New York, NY, USA). BayesX software package® (University 
of Munich, Munich, Germany) version 3.0.2, which permits Bayesian inference based on MCMC 
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2.4. Statistical Analysis
First, a descriptive analysis of behavioural and metabolic risk factors of the participants was
performed according to sex and then according to canton and municipality. The statistical significance
of probable associations between the geographic location (canton and municipality) and each
behavioural and cardio metabolic risk factor was assessed using chi-square (χ2) and Mann-Whitney
U-tests, as appropriate.
Then, to account for geographical effects on the prevalence of each risk factor, we mployed a fully
Bayesi approach using Markov Chain Monte Ca lo (MCMC) techniques for i f rence nd model
checking [28]. This was achieved using multivariate Bayesian geo-additive regression models adjusted
for age and gender; the effect of age on each risk factor was assumed to be linear. The standard
measure of effect was the posterior odds ratio (POR) and its 95% confidence interval (CI). Age- and
gender-adjusted odds ratios (ORs) of each risk factor were computed using logistic regression models,
with women and Luxembourg (at the canton and municipality level) as reference categories. Age- and
sex-adjusted total residual spatial effects were generated and presented on smoothed maps using
graduated colouring to represent the risk for each risk factor. To acc unt for the stratified random
sampling method used to r cruit the participants, weight d statistical methods were applied to produce
nationally representative estimates.
All descriptive statistical analyses were performed using PASW® for Windows® version 21.0
software (formerly SPSS Statistics Inc., New York, NY, USA). BayesX software package® (University
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of Munich, Munich, Germany) version 3.0.2, which permits Bayesian inference based on MCMC
simulation techniques which was used to map the geographic distribution of the top leading cardio
metabolic risk factors of interest.
3. Results
3.1. Subjects’ Characteristics
The ORISCAV-LUX sample consisted of 1430 participants including 734 (49.6%) women. Overall
mean age of participants was 42.02 ± 0.04. There were significant sex-specific differences in the
prevalence estimates of tobacco consumption (p-value = 0.04), alcohol use, hypertension and adiposity,
where the prevalence estimates were higher in men, except for abdominal obesity (all p-value < 0.001).
Age- and sex-adjusted prevalence estimates of smoking, high BMI (overweight/obesity), high
abdominal obesity, hypertension, diabetes, alcohol use, high TC, low eGFR and low physical activity
were 22.3%, 53.9%, 29.9%, 34.6%, 4.4%, 82.5%, 60.2%, 1.5% and 89.5%, respectively (Table 2).
Table 2. Prevalence of the top leading behavioural and metabolic risk factors according to sex among
participants in ORISCAV-LUX, 2007–2008 (N = 1430).
Overall Characteristics N * Total Sample Men Women p-Value
Total n (%) 696 (50.38) 734 (49.62)
Age, years 42.03 (0.04) 41.89 (0.06) 42.16 (0.06) 0.66
Tobacco Consumption, (%) 1430 0.04
Non-smoker 1123 (77.69) 531(75.10) 592 (80.32)
Smoker 307 (22.31) 165 (24.90) 142 (19.68)
Body Mass Index, (%) 1429 <0.001
Low BMI 621 (46.11) 227 (36.09) 394 (56.27)
High BMI 808 (53.89) 468 (63.91) 340 (43.73)
Abdominal obesity, (%) 1429 <0.001
Non-obese 968 (70.14) 505 (74.89) 463 (65.33)
Obese 461 (29.86) 190 (25.11) 271 (34.67)
Hypertension, (%) 1429 <0.001
Non-hypertensive 889 (65.42) 373 (58.04) 516 (72.91)
Hypertensive 540 (34.58) 322 (41.96) 218 (27.09)
Diabetes, (%) 1396 0.17
Non-diabetic 1327 (95.64) 638 (94.82) 689 (96.46)
Diabetic 69 (4.36) 39 (5.18) 30 (3.54)
Alcohol Consumption, (%) 1350 <0.001
Non-drinker 229 (17.53) 68 (10.91) 161 (24.25)
Drinker 1121 (82.47) 588 (89.09) 533 (75.75)
Total Cholesterol, (%) 1425 0.67
Low TC 519 (39.78) 257 (40.35) 262 (39.20)
High TC 906 (60.22) 438 (59.65) 468 (60.80)
Low eGFR, (%) 1425 0.59
≥60 1401 (98.51) 682 (98.35) 719 (98.67)
<60 24 (1.49) 13 (1.65) 11 (1.33)
Physical Activity, (%) 1364 0.65
Low physical activity 1225 (89.48) 592 (88.70) 633 (90.27)
High physical activity 139 (10.52) 70 (11.30) 69 (9.73)
p-values were calculated by using χ2 test and Mann-Whitney U-test for categorical and continuous variables, which
were presented as number (proportions in %) and means ± Standard Error, respectively. * Differences in sample
sizes are due to missing data.
3.2. Geographical Distribution of Top Leading Behavioural and Metabolic Risk Factors
Figure 2A–I depicts in maps the age- and sex-adjusted total spatial effect of each risk factor of
interest at the canton and commune level with the corresponding POR. The change of coloration
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shows the pattern of the spatial risk across the regions, with red colour indicating the highest risk
(highest values of POR) whereas the green colour indicates the lowest risk (lowest values of POR).
Next to each map representing the PORs are the corresponding posterior probabilities at 80% nominal
level, with black colour indicating a positive significant spatial effect, white indicating a negative
significant spatial effect, grey indicating a non-significant effect, and straight-lines segments indicating
no data collected from these municipalities (four municipalities). (Supplementary Tables S1–S18 show
reference tables estimating the crude prevalence of each risk factor and respective age- and sex-adjusted
OR and POR).
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Figure 2. Gender- and age-adjusted total residual spatial effects of the metabolic risk factors at the 
canton and commune level in Luxembourg. Shown are the posterior odds ratios (red colour for a high 
risk and green colour for low risk) with their corresponding posterior probabilities at 80% nominal 
level (black colour for positive significant spatial effect, white colour for negative significant spatial 
effect, grey colour for non-significant spatial effect) and straight-lines segments indicating no data 
collected from these municipalities (four municipalities). 
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3.2.3. Abdominal Obesity 
A significant variation in the prevalence estimate of abdominal obesity was observed across 
cantons (p = 0.02), ranging from 23.0% in Luxembourg to 47.6% in Redange. 
Considering the spatial effect, the highest risk was noted in the canton and municipality of 
Mersch (1.30 (0.93, 2.06)) and (1.29 (0.89, 2.20)), respectively. However, a significant negative spatial 
effect (associated with a decreased risk of abdominal obesity) was observed in the canton and 
municipality of Luxembourg (0.73 (0.53, 0.96)) and (0.75 (0.53, 0.99)), respectively (Figure 2C;  
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3.2.4. Hypertension 
The crude prevalence of hypertension ranged from the lowest in Clervaux (27.6%) to the highest 
in Vianden (66.0%). This difference was only significant across municipalities (p = 0.04). 
The maps presenting the spatial effect for hypertension showed the highest POR in the cantons 
of Vianden (1.12 (0.78, 1.04)), followed by Esch-sur-Alzette (1.08 (0.87, 1.37)) and Remich (1.07 (0.79, 
1.57)). Subjects living in the Southern Schifflange municipality (1.16 (0.80, 1.88)) were also more likely 
to be hypertensive. However, a significant negative spatial effect was observed (lowest risk) in the 
canton and municipality of Luxembourg (0.84 (0.62, 1.04)), respectively (Figure 2D; Tables S7 and S8).  
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effect, grey colour for non-significant spatial effect) and straight-lines segments indicating no data
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3.2.2. High BMI
A notable prevalence of overweight/obesity was observed in most of the cantons, ranging from
44.9% in Clerveaux to 65.1% in Echternach (p = 0.16), as well as across municipalities (p = 0.05).
Considering the spatial effect, the highest likelihood of having high BMI was noted in the canton of
Wiltz (1.11 (0.84, 1.61)) and in the municipality of Sanem (1.27 (0.89, 2.22)). A significant negative spatial
effect (associated with a reduced risk of being overweight or obese) was observed in Luxembourg
canton (0.84 (0.64, 1.03)) (Figure 2B; Tables S3 and S4).
3.2.3. Abdominal Obesity
A significant variation in the prevalence estimate of abdominal obesity was observed across
cantons (p = 0.02), ranging from 23.0% in Luxembourg to 47.6% in Redange.
Considering the spatial effect, the highest risk was noted in the canton and municipality of Mersch
(1.30 (0.93, 2.06)) and (1.29 (0.89, 2.20)), respectively. However, a significant negative spatial effect
(associated with a decreased risk of abdominal obesity) was observed in the canton and municipality
of Luxembourg (0.73 (0.53, 0.96)) and (0.75 (0.53, 0.99)), respectively (Figure 2C; Tables S5 and S6).
3.2.4. Hypertension
The crude prevalence of hypertension ranged from the lowest in Clervaux (27.6%) to the highest
in Vianden (66.0%). This difference was only significant across municipalities (p = 0.04).
The maps presenting the spatial effect for hypertension showed the highest POR in the cantons of
Vianden (1.12 (0.78, 1.04)), followed by Esch-sur-Alzette (1.08 (0.87, 1.37)) and Remich (1.07 (0.79, 1.57)).
Subjects living in the Southern Schifflange municipality (1.16 (0.80, 1.88)) were also more likely to be
hypertensive. However, a significant negative spatial effect was observed (lowest risk) in the canton
and municipality of Luxembourg (0.84 (0.62, 1.04)), respectively (Figure 2D; Tables S7 and S8).
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3.2.5. Diabetes
There were no significant differences in the crude prevalence of diabetes across cantons (p = 0.77)
and municipalities (p = 0.91). Taking into consideration the spatial effect, no remarkable variations of
diabetes risk across cantons and municipalities were observed (Figure 2E; Tables S9 and S10).
3.2.6. Alcohol Use
A high prevalence of alcohol use was registered across cantons (ranging from 90.6% in
Grevenmacher to 71.0% in Redange) and municipalities, although differences were not statistically
significant (p > 0.05).
Maps for spatial effects showed that subjects living in the southeastern region of the country,
specifically in Grevenmacher canton (1.28 (0.90, 2.31)), were more likely to consume alcohol, whereas
a significant negative spatial effect (reduced risk of alcohol use) was observed in Esch-sur-Alzette
(0.79 (0.49, 1.12)) (Figure 2F; Tables S11 and S12).
3.2.7. High Serum Total Cholesterol
Though not statistically significant, a global raised prevalence estimate of hypercholesterolemia
were observed across cantons and municipalities, ranging from the lowest in Vianden (49.3%) to the
highest in Remich (71.7%). Maps-G for spatial effect also showed non-significant variation across
cantons and municipalities, although the highest POR was noted in Remich (1.08 (0.86, 1.50)) at the
canton level and in Dalheim (1.05 (0.84, 1.39)) at the municipality level (Figure 2G; Tables S13 and S14).
3.2.8. Low eGFR
Overall, there were 24 participants with eGFR lower than 60 mL per min per 1.73 m2, constituting
a crude prevalence estimate of 1.5%. Maps-H spotted the highest POR in the canton of Remich
(1.37 (0.67, 6.08)) and the lowest in Diekirch (0.83 (0.22, 1.57)) (Figure 2H; Tables S15 and S16).
3.2.9. Low Physical Activity
There was significant variation in the practice of physical activity (equal or more than
8000 MET-min/week) across cantons and municipalities (p = 0.03 and p < 0.001, respectively), with the
lowest prevalence estimates in the Southern central belt (Luxembourg, Remich, Cappellen) compared
to the Northern regions of the country. Considering the spatial effect, map-I displayed a significant
positive spatial effect (increased risk of being inactive) in Luxembourg canton (1.47 (0.98, 2.34)) and
municipality (1.85 (1.06, 3.45)), whereas the lowest likelihood for being physical inactivity was noted
in Vianden (0.64 (0.23, 1.20)) (Figure 2I; Tables S17 and S18).
4. Discussion
This report represents the first comprehensive snapshot of the situation in regard to the
geographical variations in the top leading preventable and treatable cardio metabolic risk factors
among the general population in Luxembourg.
Our study findings are important and will be useful for informing health policy makers on how
to direct available resources toward cost-effective interventions by targeting at-risk communities.
In view of the prominent burden of CVD, this research will help to better manage and fight against
this escalating public health problem.
In general, higher concentration of smoking was observed in the northern regions, higher
overweight/obesity and abdominal obesity were clustered in the central belt, whereas hypertension
has been spotted in the southern part of the country. Noteworthy, our previous report, based on
the ORISCAV-LUX dataset, documented remarkably high prevalence estimates of major potentially
modifiable cardio metabolic risk factors among the adult residents in Luxembourg [8,17]. The present
study additionally confirmed a heterogonous geographical distribution and risk pattern of these
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factors, thus pointing to geographic gradients and inequalities across the country. These extended
findings provide added-value to our previous research on the epidemiology of cardio metabolic risk
factors in Luxembourg.
Despite the small size of Luxembourg, canton- and municipality-specific rates did not always
correspond with nationally reported rates; certain cantons/municipalities had a unique risk factor
profile. Specifically, the Bayesian maps revealed that subjects residing in Luxembourg canton were
significantly less likely to have hypertension or overweight/obesity, although they were less likely to
be practicing physical activity of ≥8000 MET-min/week. These patterns were also observed at the
level of Luxembourg municipality. Luxembourg is the capital and among the most populated sites of
Luxembourg, inhabited by people from different cultures and origins. There are many facilities for
cycling, fitness centres, but also easier access to public transport. It is possible that the people living
in Luxembourg canton use public transport and practice office-based sedentary jobs. In addition to
having lower global and abdominal obesity, the Luxembourg canton inhabitants would have a pretext
for being less physically active, although further research is needed to prove this theory. In contrast
to Luxembourg canton/municipality, the canton and municipality of Mersch were characterized by
subjects with high abdominal obesity risk profiles.
The likelihood of alcohol use was remarkably low in Esch-sur-Alzette, a canton situated in the
southwestern industrial area. Notably, an agglomeration of alcohol use was observed in Remich and
Grevenmacher, wine-making dominated areas. Statistically, there were non-significant spatial patterns
regarding smoking, diabetes, total serum cholesterol, and low eGFR risk distribution.
Our findings confirmed that when cantons and municipalities were analysed individually,
there was a variability in risk factor profiles. Although not striking, these variances imply that
geography-specific culture or spatial-related conditions might impact subjects’ behavioural and
biological characteristics irrespective of their age and sex. Nevertheless, we should be cautious
in the interpretation of the observed geographical variation due to the low number of participants in
several relatively small municipalities.
Among a few similar studies, important geographical disparities in cardio metabolic risk factors
have been reported in Europe [29] and worldwide [9–14]. To our knowledge, this is the first most
comprehensive study to address the spatial effect of top leading behavioural and cardio metabolic
risk factors in Luxembourg. Each risk factor had a different distribution among the 12 cantons and
106 municipalities over the country, suggesting the potential role of geographical factors. The present
findings may provide evidence of the environmental role in the pathogenesis of CVD.
The reasons for the geographical differences in the patterns of selected risk factors are likely
to be complex. One potential reason for geographic gradients in health is that they might simply
reflect a concentration of people with lower socio-economic status, with their concordant health
problems [29,30]. In a relatively homogenous country such as Luxembourg, urban versus rural areas
are difficult to distinguish. Nevertheless, some of the variances between cantons and municipalities
would be partially explained by the differences in the characteristics of individual areas within these
regions. It would be plausible that people residing in Luxembourg municipality, classified as urban
or more prosperous, would have better health status than those cantons/municipalities labelled as
rural or relatively deprived. Additionally, the distribution of healthcare facilities is more favourable in
the south and central part of the country, although regional resources are generally well allocated to
meet the public’s health needs. Further research should focus on the characteristics of areas and the
interplay between place and individuals.
Although we may not understand all the nuances that create risk factor variance, recognizing
risk areas of a country serves to improve preventive initiatives so that resources are allocated only
for necessary intervention (e.g., increase awareness for high abdominal obesity in Mersch and lower
physical activity in Luxembourg). Consequently, these findings may help public health officials,
medical professionals and health promoters to develop targeted prevention plans to narrow the gap
and eliminate risk disparities for CVD in Luxembourg.
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Noteworthy, the administrations of each municipality develop their own initiatives for health
promotion of the inhabitants. It would be more appropriate to harmonize the efforts to bring
improvements in health across the country and to reduce health inequalities.
There are several caveats to consider with this study. First, the cross-sectional design does
not permit any causal inference regarding geographical location and the selected cardio metabolic
risk factors, though reverse causation in this context is unlikely. Second, although remarkable
between-municipalities and between-cantons variances exist, residual confounding related to
socio-economic, dietary and lifestyle behaviours cannot be ruled out as a possible explanation for the
observed findings. To confirm that the observed differences are independently related to geographic
reasons, or, in other words, that the geographic inequalities are merely a result of differences in the
socio-economic structure of the areas, further adjustments to these confounders are warranted.
Despite these limitations, our study expands the body of knowledge regarding a global vision
of the geographical epidemiology of these cardio metabolic risk factors in Luxembourg, a small
representative centrally-located European country. Using a nationwide representative sample of the
adult population residing in the country, this study demonstrated remarkable geographic differences
in the prevalence of the major behavioural and metabolic risk factors across cantons and municipalities.
These findings are of particular interest at the European level, as they advance the hypothesis of
European disparities in the distribution of cardio metabolic risk factors among other European
countries. Our findings contribute to filling gaps on the worldwide map examining variations in
geographical risk distribution.
Additionally, the strengths of the study reside first in the inclusion of a large nationally
representative population-based sample of adults. Second, the comparison of known demographic and
cardiovascular health-related profiles of the participants and non-participants to the ORISCAV-LUX
survey was demonstrated earlier [19]; the participants did not differ substantially from the
non-participants, and the response rate allowed the findings to be generalized for the entire population.
Third, although the young age group was underrepresented in the sample, the data were weighted to
provide population-representative prevalence estimates. Fourth, the ORISCAV-LUX survey provided
reliable objective measurements, performed by well-trained personnel, of major cardio metabolic risk
factors, namely, obesity, diabetes, hypertension, low eGFR and lipid disorders. This helps in avoiding
the retrieval of these factors from relatively inaccurate self-administered information, though smoking,
alcohol use and physical activity were based on self-reported data.
5. Conclusions
In conclusion, this study provides a national vision for the global burden of CVD in Luxembourg
by presenting the geographical mapping of the top leading behavioural and metabolic risk factors.
It shows that there is significant variation in the distribution of several preventable and treatable risk
factors, in particular hypertension, overweight/obesity, and physical inactivity among the cantons
and municipalities of Luxembourg. Along with the rising burden of these risk factors and associated
pathologies, our findings have practical implications for healthcare practitioners and policy makers.
Further prevention measures at specific canton/municipality levels should be considered to address
the observed geographic inequalities.
Supplementary Materials: The following are available online at www.mdpi.com/1660-4601/14/6/648/s1,
Tables S1–S18: Results of descriptive, multivariable logistic. Bayesian regression analyses (based on MCMC
technique) for the nine selected leading behavioural and metabolic risk factors.
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